NCT00060944 2014-09-08A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced CancerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2 Completed271 enrolled 13 charts